Full Text View
Tabular View
No Study Results Posted
Related Studies
Double-Blind Placebo-Controlled Trial of Riluzole in Pediatric Bipolar Disorder
This study is currently recruiting participants.
Study NCT00805493   Information provided by National Institutes of Health Clinical Center (CC)
First Received: December 6, 2008   Last Updated: October 8, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Bipolar Disorder
Anxiety Disorders
Bipolar Affective Disorder
Bipolar Depression
Additional conditions recognized in this trial
Depression
Depressive Disorder
Disease
Mood Disorders
More general conditions related to this trial
Affective Disorders, Psychotic
Behavioral Symptoms
Mental Disorders
Pathologic Processes
Interventions listed in this trial
Riluzole
More general drug interventions related to this trial
Anticonvulsants
Central Nervous System Agents
Excitatory Amino Acid Agents
Excitatory Amino Acid Antagonists
Molecular Mechanisms of Pharmacological Action
Neuroprotective Agents
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Therapeutic Uses
Sponsors listed in this trial
National Institute of Mental Health (NIMH)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services